The pharmacokinetics of caffeine in Nigerian children suffering from malaria and kwashiorkor.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 2, p. 153, doi. 10.1007/s002280050734
- By:
- Publication type:
- Article
Works matching IS 00316970 AND DT 2000 AND VI 56 AND IP 2
Results: 14
1
2
Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 2, p. 181, doi. 10.1007/s002280050738
- By:
- Publication type:
- Article
3
The effects of acute falciparum malaria on the disposition of caffeine and the comparison of saliva and plasma-derived pharmacokinetic parameters in adult Nigerians.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 2, p. 159, doi. 10.1007/s002280050735
- By:
- Publication type:
- Article
4
Modulation of midazolam 1-hydroxylation activity in vitro by neurotransmitters and precursors.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 2, p. 145
- By:
- Publication type:
- Article
5
Absorption of effervescent paracetamol tablets relative to ordinary paracetamol tablets in healthy volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 2, p. 141, doi. 10.1007/s002280050732
- By:
- Publication type:
- Article
6
In vitro inhibition screening of human hepatic P<sub>450</sub> enzymes by five angiotensin-II receptor antagonists.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 2, p. 135, doi. 10.1007/s002280050731
- By:
- Publication type:
- Article
7
Mealtime glucose regulation by nateglinide in type-2 diabetes mellitus.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 2, p. 129, doi. 10.1007/s002280050730
- By:
- Publication type:
- Article
8
Fluvoxamine but not citalopram increases serum melatonin in healthy subjects – an indication that cytochrome P<sub>450</sub> CYP1A2 and CYP2C19 hydroxylate melatonin.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 2, p. 123, doi. 10.1007/s002280050729
- By:
- Publication type:
- Article
9
Book reviews.
- Published in:
- 2000
- Publication type:
- Book Review
10
Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 2, p. 167
- By:
- Publication type:
- Article
11
Announcements.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 2, p. 197, doi. 10.1007/s002280050742
- Publication type:
- Article
12
Co-trimoxazole-induced liver and renal failure : Case report.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 2, p. 191, doi. 10.1007/s002280050740
- By:
- Publication type:
- Article
13
Liver injury caused by ebrotidine: a new example of the utility of the postmarketing surveillance.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 2, p. 187, doi. 10.1007/s002280050739
- By:
- Publication type:
- Article
14
The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 2, p. 175, doi. 10.1007/s002280050737
- By:
- Publication type:
- Article